Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
Methods Mol Biol ; 758: 215-35, 2011.
Article in English | MEDLINE | ID: mdl-21815069

ABSTRACT

Drug discovery and therapeutic development for disorders of the central nervous system (CNS) represents one of the largest unmet markets in modern medicine. We have increasingly recognized that the lack of stringent assessment of mitochondrial function during the discovery process has resulted in drug recalls, black box warnings, and an urgent need to understand the metabolic liability of small molecules in neural systems. Given that the brain is the most energetically demanding organ, even modest perturbations in neuronal energetic pathways have been shown to impact growth, signaling, connectivity, and the restorative capacity of the CNS. In this work, we describe several tools to assess metabolic activity of primary neuronal cultures and neural cell lines using an acute model of injury induced by oxygen glucose deprivation. Methods include the measurement of total ATP and NADH, enzymatic assessment of lactate production by anaerobic respiration, as well as viability assays. We also present a modified screening method for assessing aerobic respiration of immortalized cell lines using galactose challenge.


Subject(s)
Energy Metabolism , Neurons/metabolism , Adenosine Triphosphate/chemistry , Adenosine Triphosphate/metabolism , Animals , Brain/cytology , Brain/metabolism , Cell Extracts/chemistry , Cell Hypoxia , Cell Line, Tumor , Cell Survival , Embryo, Mammalian/cytology , Female , Galactose/chemistry , Galactose/metabolism , Glucose/chemistry , Glucose/metabolism , Humans , L-Lactate Dehydrogenase/chemistry , L-Lactate Dehydrogenase/metabolism , Lactic Acid/chemistry , Lactic Acid/metabolism , Pregnancy , Pyruvic Acid/chemistry , Pyruvic Acid/metabolism , Rats
2.
Antioxid Redox Signal ; 14(10): 1787-801, 2011 May 15.
Article in English | MEDLINE | ID: mdl-20677910

ABSTRACT

The decision to remove or refold oxidized, denatured, or misfolded proteins by heat shock protein 70 and its binding partners is critical to determine cell fate under pathophysiological conditions. Overexpression of the ubiquitin ligase C-terminus of HSC70 interacting protein (CHIP) can compensate for failure of other ubiquitin ligases and enhance protein turnover and survival under chronic neurological stress. The ability of CHIP to alter cell fate after acute neurological injury has not been assessed. Using postmortem human tissue samples, we provide the first evidence that cortical CHIP expression is increased after ischemic stroke. Oxygen glucose deprivation in vitro led to rapid protein oxidation, antioxidant depletion, proteasome dysfunction, and a significant increase in CHIP expression. To determine if CHIP upregulation enhances neural survival, we overexpressed CHIP in vitro and evaluated cell fate 24 h after acute oxidative stress. Surprisingly, CHIP overexpressing cells fared worse against oxidative injury, accumulated more ubiquitinated and oxidized proteins, and experienced decreased proteasome activity. Conversely, using small interfering RNA to decrease CHIP expression in primary neuronal cultures improved survival after oxidative stress, suggesting that increases in CHIP observed after stroke like injuries are likely correlated with diminished survival and may negatively impact the neuroprotective potential of heat shock protein 70.


Subject(s)
Oxidative Stress/physiology , Stroke/metabolism , Ubiquitin-Protein Ligases/metabolism , Animals , Cell Line, Tumor , Cells, Cultured , Chromatin Immunoprecipitation , Chromatography, High Pressure Liquid , Fluorescent Antibody Technique , Glutathione/metabolism , Glutathione Disulfide/metabolism , Immunoblotting , Mice , Oxidative Stress/genetics , Rats , Rats, Sprague-Dawley , Stroke/genetics , Ubiquitin-Protein Ligases/genetics
3.
Autophagy ; 6(7): 948-9, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20724835

ABSTRACT

Stroke is the leading cause of adult disability in the U.S. and is now recognized as a global epidemic. There are currently no FDA-approved drugs to block the cell death that results from oxygen and glucose deprivation. This void in clinical medicine has sparked an intense interest in understanding endogenous cellular protective pathways that might be exploited for therapeutic development. The work highlighted here describes the critical role between redox tone and energetic stress signaling in mediating mitophagy and determining neuronal cell fate following acute oxygen glucose deprivation.


Subject(s)
Autophagy/physiology , Mitochondria/metabolism , Neurons/metabolism , Neurons/ultrastructure , Oxidation-Reduction , Shc Signaling Adaptor Proteins/metabolism , Adult , Cells, Cultured , Humans , Ischemic Preconditioning , Neurons/cytology , Protein Kinases/metabolism , Shc Signaling Adaptor Proteins/genetics , Signal Transduction/physiology , Src Homology 2 Domain-Containing, Transforming Protein 1 , Stroke/pathology , Stroke/physiopathology
4.
Biochim Biophys Acta ; 1802(11): 1095-104, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20656023

ABSTRACT

Prior exposure to sub toxic insults can induce a powerful endogenous neuroprotective program known as ischemic preconditioning. Current models typically rely on a single stress episode to induce neuroprotection whereas the clinical reality is that patients may experience multiple transient ischemic attacks (TIAs) prior to suffering a stroke. We sought to develop a neuron-enriched preconditioning model using multiple oxygen glucose deprivation (OGD) episodes to assess the endogenous protective mechanisms neurons implement at the metabolic and cellular level. We found that neurons exposed to a five minute period of glucose deprivation recovered oxygen utilization and lactate production using novel microphysiometry techniques. Using the non-toxic and energetically favorable five minute exposure, we developed a preconditioning paradigm where neurons are exposed to this brief OGD for three consecutive days. These cells experienced a 45% greater survival following an otherwise lethal event and exhibited a longer lasting window of protection in comparison to our previous in vitro preconditioning model using a single stress. As in other models, preconditioned cells exhibited mild caspase activation, an increase in oxidized proteins and a requirement for reactive oxygen species for neuroprotection. Heat shock protein 70 was upregulated during preconditioning, yet the majority of this protein was released extracellularly. We believe coupling this neuron-enriched multi-day model with microphysiometry will allow us to assess neuronal specific real-time metabolic adaptations necessary for preconditioning.


Subject(s)
Adaptation, Physiological , Glucose/metabolism , Neurons/metabolism , Oxygen/metabolism , Animals , Blotting, Western , Caspase 3/metabolism , Cell Hypoxia , Cells, Cultured , Energy Metabolism/drug effects , Enzyme Activation/drug effects , Glucose/pharmacology , HSP70 Heat-Shock Proteins/metabolism , Immunohistochemistry , Neurons/cytology , Neurons/drug effects , Oxygen/pharmacology , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Stress, Physiological , Time Factors
5.
J Neurosci ; 30(15): 5242-52, 2010 Apr 14.
Article in English | MEDLINE | ID: mdl-20392947

ABSTRACT

Ischemic preconditioning is a phenomenon in which low-level stressful stimuli upregulate endogenous defensive programs, resulting in subsequent resistance to otherwise lethal injuries. We previously observed that signal transduction systems typically associated with neurodegeneration such as caspase activation are requisite events for the expression of tolerance and induction of HSP70. In this work, we sought to determine the extent and duration of oxidative and energetic dysfunction as well as the role of effector kinases on metabolic function in preconditioned cells. Using an in vitro neuronal culture model, we observed a robust increase in Raf and p66(Shc) activation within 1 h of preconditioning. Total ATP content decreased by 25% 3 h after preconditioning but returned to baseline by 24 h. Use of a free radical spin trap or p66(shc) inhibitor increased ATP content whereas a Raf inhibitor had no effect. Phosphorylated p66(shc) rapidly relocalized to the mitochondria and in the absence of activated p66(shc), autophagic processing increased. The constitutively expressed chaperone HSC70 relocalized to autophagosomes. Preconditioned cells experience significant total oxidative stress measured by F(2)-isoprostanes and neuronal stress evaluated by F(4)-neuroprostane measurement. Neuroprostane levels were enhanced in the presence of Shc inhibitors. Finally, we found that inhibiting either p66(shc) or Raf blocked neuroprotection afforded by preconditioning as well as upregulation of HSP70, suggesting both kinases are critical for preconditioning but function in fundamentally different ways. This is the first work to demonstrate the essential role of p66(shc) in mediating requisite mitochondrial and energetic compensation after preconditioning and suggests a mechanism by which protein and organelle damage mediated by ROS can increase HSP70.


Subject(s)
Ischemic Preconditioning , Neurons/physiology , Oxidative Stress/physiology , Shc Signaling Adaptor Proteins/metabolism , Adenosine Triphosphate/metabolism , Animals , Autophagy/drug effects , Autophagy/physiology , Cell Nucleus/drug effects , Cell Nucleus/enzymology , Cell Nucleus/physiology , Cells, Cultured , Docosahexaenoic Acids/metabolism , HSC70 Heat-Shock Proteins/metabolism , Isoprostanes/metabolism , Mitochondria/drug effects , Mitochondria/enzymology , Mitochondria/physiology , Neurons/drug effects , Neurons/enzymology , Oxidative Stress/drug effects , Phosphorylation , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Shc Signaling Adaptor Proteins/antagonists & inhibitors , Src Homology 2 Domain-Containing, Transforming Protein 1 , Time Factors , raf Kinases/antagonists & inhibitors , raf Kinases/metabolism
6.
Free Radic Biol Med ; 47(10): 1422-31, 2009 Nov 15.
Article in English | MEDLINE | ID: mdl-19699297

ABSTRACT

Stroke is the third leading cause of death in the United States, yet no neuroprotective agents for treatment are clinically available. There is a pressing need to understand the signaling molecules that mediate ischemic cell death and identify novel neuroprotective targets. Cyclopentenone isoprostanes (IsoPs), formed after free radical-mediated peroxidation of arachidonic acid, are used as markers of stress, but their bioactivity is poorly understood. We have recently shown that 15-A(2t)-IsoP is a potent neurotoxin in vitro and increases the free radical burden in neurons. In this work, we demonstrate that 15-A(2t)-IsoP is abundantly produced in stroke-infarcted human cortical tissue. Using primary neuronal cultures we found that minimally toxic exposure to 15-A(2t)-IsoP does not alter ATP content, but in combination with oxygen glucose deprivation resulted in a significant hyperpolarization of the mitochondrial membrane and dramatically increased neuronal cell death. In the presence of Ca(2+), 15-A(2t)-IsoP led to a rapid induction of the permeability transition pore and release of cytochrome c. Taken with our previous work, these data support a model in which ischemia causes generation of reactive oxygen species, calcium influx, lipid peroxidation, and 15-A(2t)-IsoP formation. These factors combine to enhance opening of the permeability transition pore leading to cell death subsequent to mitochondrial cytochrome c release. These data are the first documentation of significant 15-A(2t)-IsoP formation after acute ischemic stroke and suggest that the addition of 15-A(2t)-IsoP to in vitro models of ischemia may help to more fully recapitulate stroke injury.


Subject(s)
Lipid Peroxidation , Neurons/metabolism , Prostaglandins A/biosynthesis , Reactive Oxygen Species/metabolism , Reperfusion Injury/metabolism , Stroke/metabolism , Animals , Calcium/pharmacology , Cells, Cultured , Cytochromes c/drug effects , Cytochromes c/metabolism , Dose-Response Relationship, Drug , Humans , Mass Spectrometry , Mitochondria/drug effects , Mitochondria/metabolism , Neurons/cytology , Neurons/drug effects , Prostaglandins A/chemistry , Prostaglandins A/toxicity , Rats , Rats, Sprague-Dawley , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL